Suvorexant

ATC N05CJ01 · 3 markets · 11 records

Suvorexant 3 markets · 11 records Forms

US 4 records · 4 strengths

20 mgtabletBELSOMRA also in AU
15 mgtabletBELSOMRA also in AU
10 mgtabletBELSOMRA
5 mgtabletBELSOMRA

AU 3 records · 3 strengths

20 mgtabletBELSOMRA suvorexant 15mg tablet blister pack also in US unknown
15 mgtabletBELSOMRA suvorexant 15mg tablet blister pack also in US unknown

Records without a stated strength · 1 BELSOMRA

Side-by-side table

Strength / form / release	US	AU
20 mg tablet	BELSOMRA	BELSOMRA suvorexant 15mg tablet blister pack
15 mg tablet	BELSOMRA	BELSOMRA suvorexant 15mg tablet blister pack
10 mg tablet	BELSOMRA	not recorded
5 mg tablet	BELSOMRA	not recorded
not disclosed unknown	not recorded	BELSOMRA

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.